Q9BYW2 (SETD2_HUMAN) Homo sapiens (Human)
Histone-lysine N-methyltransferase SETD2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
33 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| RNA polymerase II-DSIF-SPT6-PAF1c-TFIIS-IWS1-SETD2-nucleosome, 30 bp upstream |
Heteromer A0A310TTQ1; A0A481DF93; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A7M4DUC2; A0A8D0TE17; A0A8D1AQR7; A0A8W4F9W9; O00267; P02281; P06897; P23193; P60899; P62799; P63272; Q6P1J9; Q6PD62; Q7KZ85; Q8N7H5; Q8WVC0; Q92541; Q96ST2; Q9GZS3; | 100.0 | 9×ZN; 1×MG; | |||
| RNA polymerase II-DSIF-SPT6-PAF1c-TFIIS-IWS1-SETD2-nucleosome, 20 bp upstream |
Heteromer A0A310TTQ1; A0A481DF93; A0A4X1TVZ5; A0A4X1VKG7; A0A4X1VTX4; A0A8D0JYF1; A0A8D1DS11; A0A8D1QTB4; F1RKE4; I3LCB2; P02281; P06897; P23193; P60899; P62799; P63272; Q6P1J9; Q6PD62; Q92541; Q96ST2; Q9GZS3; | 100.0 | 9×ZN; 1×MG; | |||
| Crystal structure of SETD2 bound to histone H3.3 K36I peptide |
Heteromer P84243; | 100.0 | 1×SAH; 3×SCN; 2×GOL; 3×ZN; | |||
| crystal structure of SESTD2 in complex with H3.3S31phK36M peptide |
Heteromer P84243; | 99.59 | 3×ZN; 1×SAH; 4×SCN; | |||
| Structure of the lysine methyltransferase SETD2 in complex with a peptide derived from human tyrosi… |
Heteromer Q07912; | 100.0 | 3×ZN; 1×SAM; | |||
| Crystal structure of SETD2 bound to histone H3.3 K36M peptide |
Heteromer P84243; | 100.0 | 3×ZN; 1×SAH; 5×SCN; | |||
| Crystal structure of human SETD2 SET-domain in complex with H3K36M peptide and SAH |
Heteromer P68431; | 100.0 | 3×ZN; 1×SAH; | |||
| Crystal structure of human SETD2 SET-domain in complex with H3K36M peptide and SAM |
Heteromer P68431; | 100.0 | 3×ZN; 1×SAM; | |||
| Human SETD2 bound to a nucleosome containing oncohistone mutations |
Heteromer P06899; P20671; P62799; Q6PI79; | 100 | 3×ZN; 1×SAM; | |||
| RNA polymerase II-DSIF-SPT6-PAF1c-TFIIS-IWS1-SETD2-nucleosome, bp +27 |
Heteromer A0A310TTQ1; A0A481DF93; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A7M4DUC2; A0A8D0TE17; A0A8D1AQR7; A0A8W4F9W9; O00267; P02281; P06897; P23193; P60899; P62799; P63272; Q6P1J9; Q6PD62; Q7KZ85; Q8N7H5; Q8WVC0; Q92541; Q96ST2; Q9GZS3; | 100 | 12×ZN; 1×MG; | |||
| Crystal structure of hnRNP L RRM2 in complex with SETD2 |
Heteromer P14866; | 100 | ||||
| RNA polymerase II-DSIF-SPT6-PAF1c-TFIIS-IWS1-SETD2-FACT nucleosome upstream |
Heteromer A0A310TTQ1; A0A481DF93; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A7M4DUC2; A0A8D0TE17; A0A8D1AQR7; A0A8W4F9W9; O00267; P02281; P06897; P23193; P60899; P62799; P63272; Q08945; Q6P1J9; Q6PD62; Q7KZ85; Q8N7H5; Q8WVC0; Q92541; Q96ST2; Q9GZS3; Q9Y5B9; | 100 | 9×ZN; 1×MG; | |||
| Crystal structure of hnRNP LL RRM2 in complex with SETD2 |
Heteromer Q8WVV9; | 100 | 1×SO4; | |||
| Structure of the Epigenetic Oncogene MMSET and inhibition by N-Alkyl Sinefungin Derivatives | monomer | 100.0 | 3×ZN; 2×SCN; 1×76L; | |||
| Structure of the Epigenetic Oncogene MMSET and inhibition by N-Alkyl Sinefungin Derivatives | monomer | 100.0 | 3×ZN; 1×SCN; 1×76M; | |||
| Structure of the Epigenetic Oncogene MMSET and inhibition by N-Alkyl Sinefungin Derivatives | monomer | 100.0 | 3×ZN; 2×SCN; 1×76K; | |||
| SETD2 in complex with a H3-variant super-substrate peptide | monomer | 100.0 | 1×SAH; 20×UNX; 3×ZN; 1×SCN; | |||
| Crystal structure of Methyltransferase domain of human SET domain-containing protein 2 Compound: Pr… | monomer | 100.0 | 3×ZN; 1×0UM; 13×UNX; | |||
| Crystal Structure of SETD2 Bound to an Indole-based Inhibitor | monomer | 100.0 | 3×ZN; 1×SAM; 1×KRF; 1×EDO; | |||
| Crystal Structure of SETD2 bound to Compound 57 | monomer | 100.0 | 3×ZN; 1×SAM; 1×YHV; 1×EDO; | |||
| Structure of the Epigenetic Oncogene MMSET and inhibition by N-Alkyl Sinefungin Derivatives | monomer | 100.0 | 3×ZN; 1×SCN; 1×76H; | |||
| Crystal Structure of SETD2 bound to Compound 35 | monomer | 100.0 | 3×ZN; 1×SAM; 1×YHY; 9×EDO; 1×DMS; | |||
| Crystal Structure of SETD2 Bound to an Indole-based Inhibitor | monomer | 100.0 | 3×ZN; 1×SAM; 1×KS6; | |||
| Crystal Structure of SETD2 bound to Compound 2 | monomer | 100.0 | 3×ZN; 1×SAM; 1×YJ1; 1×BME; | |||
| Structure of the Epigenetic Oncogene MMSET and inhibition by N-Alkyl Sinefungin Derivatives | monomer | 100.0 | 3×ZN; 1×76O; | |||
| Structure of the Epigenetic Oncogene MMSET and inhibition by N-Alkyl Sinefungin Derivatives | monomer | 100.0 | 3×ZN; 1×SFG; | |||
| Structure of the Epigenetic Oncogene MMSET and inhibition by N-Alkyl Sinefungin Derivatives | monomer | 100.0 | 3×ZN; 1×SCN; 1×76J; | |||
| The crystal structure of methyltransferase domain of human SET domain-containing protein 2 in compl… | monomer | 100.0 | 3×ZN; 1×SAH; 1×CL; | |||
| Crystal structure of SETD2 bound to SAH | monomer | 100.0 | 3×ZN; 1×SAH; | |||
| Solution Structure of the hSet2/HYPB SRI domain | monomer | 100 | ||||
| Solution structure of WW domain with polyproline stretch (PP2WW) of HYPB | monomer | 100 | ||||
| Solution structure of the PP2WW mutant (KPP2WW) of HYPB | monomer | 94.44 | ||||
| Solution structure of the WW domain of HYPB | monomer | 100 | ||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2a7o.1.A | monomer | 0.85 | 100.00 | |||
| 5lsx.1.A | monomer | 0.72 | 3×ZN; 1×76O; | 100.00 | ||
| 6zv2.1.A | monomer | 0.54 | 21.24 | |||
3 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 5lsx.1.A | monomer | 0.75 | 3×ZN; 1×76O; | 100.00 | ||
| Isoform 3 | 5lsx.1.A | monomer | 0.71 | 2×ZN; | 100.00 | ||
| Isoform 3 | 6ine.1.A | monomer | 0.56 | 2×ZN; | 30.43 | ||